Colon Cancer in the Land of NOD: NLRX1 as an Intrinsic Tumor Suppressor

Trends in Immunology

Volumn 37, Issue 9, 2016, Pages 569-570

  Lei, Andrea ^a   Maloy, Kevin J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CRE RECOMBINASE; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NLRX1 PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; STAT3 PROTEIN; UNCLASSIFIED DRUG; VILLIN; MITOCHONDRIAL PROTEIN; NLRX1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

CARCINOGENESIS; CELL PROLIFERATION; COLITIS; COLON CANCER; COLORECTAL CANCER; CRYPT CELL; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE REPAIR; TUMOR VOLUME; WOUND HEALING; ANIMAL; COLON TUMOR; GASTRITIS; GENETICS; HOMEOSTASIS; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; KNOCKOUT MOUSE; MENINGITIS; METABOLISM; MOUSE; PATHOLOGY; PNEUMONIA;

ANIMALS; CELL PROLIFERATION; COLONIC NEOPLASMS; GASTRITIS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; MENINGITIS; MICE; MICE, KNOCKOUT; MITOCHONDRIAL PROTEINS; PNEUMONIA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84992500314     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.07.004     Document Type: Short Survey

References (10)

1. 1 Lamkanfi, M., Dixit, V.M., Mechanisms and functions of inflammasomes. Cell 157 (2014), 1013–1022.
2. 2 Sellin, M.E., et al. Inflammasomes of the intestinal epithelium. Trends Immunol. 36 (2015), 442–450.
3. 3 Elinav, E.J., et al. Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol. 6 (2013), 4–13.
4. 4 Tattoli, I., et al. NLRX1 Acts as an epithelial-intrinsic tumor suppressor through the modulation of TNF-mediated proliferation. Cell Rep. 14 (2016), 2576–2586.
5. 5 Koblansky, A.A., et al. The innate immune receptor NLRX1 functions as a tumor suppressor by reducing colon tumorigenesis and key tumor-promoting signals. Cell Rep. 14 (2016), 2562–2575.
6. 6 Eitas, T.K., et al. The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation. J. Biol. Chem. 289 (2014), 4173–4179.
7. 7 Kang, M-J., et al. Suppression of NLRX1 in chronic obstructive pulmonary disease. J. Clin. Invest. 125 (2015), 2458–2462.
8. 8 Soares, F., et al. The mitochondrial protein NLRX1 controls the balance between extrinsic and intrinsic apoptosis. J. Biol. Chem. 289 (2014), 19317–19330.
9. 9 Allen, I.C., et al. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-κB signaling pathways. Immunity 34 (2011), 854–865.
10. 10 Neurath, M.F., Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14 (2014), 329–342.